This article is more than 5 years old. Information may no longer be current.

HemOnc Today’s top 10 stories from 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The top stories in hematology and oncology this year included articles on study results published in peer-reviewed journals, FDA approvals and practice-changing data presented at scientific meetings, as well as articles that featured interviews with leading researchers and expert opinions on approaches to patient care.

HemOnc Today presents the top 10 most read stories from this year.

1. New strategies are needed to improve childhood cancer survivors’ adherence to long-term follow-up. Read more.

2. Men with Peyronie’s disease demonstrated an increased risk for cancer. Read more.

3. A virtual reality initiative showed benefit for adolescents and young adults with cancer. Read more.

4. The FDA granted orphan drug designation to BI 836858 (Boehringer Ingelheim) for the treatment of myelodysplastic syndrome. Read more.

5. Patients with melanoma who responded to immunotherapy had a more diverse gut microbiome than nonresponders. Read more.

6. The investigational hallucinogenic drug psilocybin reduced clinician- and patient-reported depression, anxiety and mortality-associated anxiety among adults with cancer. Read more.

7. Patients with oral squamous cell carcinoma reported significant declines in the frequency of vaginal and oral sex after their diagnosis, regardless of tumor HPV status. Read more.

8. Cryoablation appeared to be a safe and effective alternative to surgery for women with early-stage small breast cancers. Read more.

9. Aldoxorubicin monotherapy appeared well tolerated and may improve outcomes compared with standard treatments for relapsed/refractory soft tissue sarcoma. Read more.

10. Malnutrition is “almost epidemic” among patients with advanced cancer. Read more.